Osaic Holdings’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$48.7K Sell
7,759
-1,092
-12% -$9.06K ﹤0.01% 5531
2026
Q2
$83.9K Buy
8,851
+450
+5% +$3.85K ﹤0.01% 5093
2026
Q1
$46.4K Buy
8,401
+2,111
+34% +$23.4K ﹤0.01% 5285
2025
Q4
$166K Sell
6,290
-105
-2% -$2.03K ﹤0.01% 4295
2025
Q3
$79K Buy
6,395
+1,425
+29% +$22.2K ﹤0.01% 4975
2025
Q2
$96.6K Buy
4,970
+4,083
+460% +$79.2K ﹤0.01% 4528
2025
Q1
$12.7K Buy
887
+333
+60% +$6.38K ﹤0.01% 5651
2024
Q4
$13.7K Buy
+554
New +$15.5K ﹤0.01% 5595

Other funds holding GUTS

Osaic Holdings's GUTS Position: Q3 2026 in Review

Osaic Holdings reduced its Fractyl Health (GUTS) stake by 12% in Q3 2026, selling an estimated $9.06K and leaving 7,759 shares worth $48.7K. The position accounts for ﹤0.01% of the portfolio, ranked #5531.

Osaic Holdings first reported a position in GUTS in Q4 2024 and has held it in 8 quarters since. The position peaked at $166K in Q4 2025. 49 funds tracked by Wall St. Rank hold GUTS as of Q3 2026.

  • Osaic Holdings held 7,759 shares of Fractyl Health worth $48.7K as of Q3 2026.
  • Osaic Holdings sold 1,092 Fractyl Health shares in Q3 2026, an estimated $9.06K.
  • Fractyl Health made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #5531 holding.
  • Osaic Holdings first reported a position in Fractyl Health in Q4 2024 and has held it in 8 quarters since.
  • Osaic Holdings's Fractyl Health position peaked at $166K in Q4 2025.
  • 49 funds tracked by Wall St. Rank held Fractyl Health as of Q3 2026.

Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.